Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists - mechanisms, clinical evidence, and therapeutic perspectives Hepatoma Res
Head-to-head comparative trials and studies of combination regimens are needed to establish optimal treatment sequencing and identify which patients benefit most from each approach or from their combination
Key Takeaway: Because GLP-1 medications stay in your system for several days, the specific hour you choose for your weekly injection has less to do with the drugs strength and more to do with your lifestyle and comfort
The American Journal of Clinical Nutrition , 87(1), 155S158S
By working on two hormones, it often leads to greater reductions in weight and blood sugar compared to semaglutide
This proactive oversight prevents complications and maintains patient confidence